Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma von Fields, R C, Strong, V E, Gönen, M, Goodman, K A, Rizk, N P, Kelsen, D P, Ilson, D H, Tang, L H, Brennan, M F, Coit, D G, Shah, M A

Volltext

Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience von Ku, G.Y., Minsky, B.D., Rusch, V.W., Bains, M., Kelsen, D.P., Ilson, D.H.

Volltext

Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer von Ilson, DH, Wadleigh, RG, Leichman, LP, Kelsen, DP

Volltext

Combined modality chemoradiation in elderly oesophageal cancer patients von Anderson, S E, Minsky, B D, Bains, M, Hummer, A, Kelsen, D, Ilson, D H

Volltext

Is there a future for EGFR targeted agents in esophageal cancer? von Ilson, D.H.

Volltext

Phase II Trial of Weekly Irinotecan Plus Cisplatin in Advanced Esophageal Cancer von ILSON, D. H, SALTZ, L, KELSEN, D. P, ENZINGER, P, YING HUANG, KORNBLITH, A, GOLLUB, M, O'REILLY, E, SCHWARTZ, G, DEGROFF, J, GONZALEZ, G

Volltext

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus von ILSON, D. H, AJANI, J, KELSEN, D. P, BHALLA, K, FORASTIERE, A, YING HUANG, PATEL, P, MARTIN, L, DONEGAN, J, PAZDUR, R, REED, C

Volltext

Overall survival results from a phase III trial of trifluridine/tipiracil (FTD/TPI) vs placebo in patients (Pts) with metastatic gastric cancer refractory to standard therapies (TA... von Shitara, K., Tabernero, J., Dvorkin, M., Mansoor, W., Arkenau, H.-T., Prokharau, A., Alsina, M., Ghidini, M., Faustino, C., Gorbunova, V., Zhavrid, E., Nishikawa, K., Hosokawa, A., Ganea, D., Yalçın, Ş., Fujitani, K., Beretta, G., Winkler, R., Doi, T., Ilson, D.H.

Volltext

Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus von Ajani, Jaffer A., Ilson, David H., Daugherty, Karen, Pazdur, Richard, Lynch, Patrick M., Kelsen, David P

Volltext

TAGS: A phase III, randomised, double-blind study of trifluridine/tipiracil (TAS-102) versus placebo in patients with refractory metastatic gastric cancer von Arkenau, H.-T., Tabernero, J., Shitara, K., Dvorkin, M., Mansoor, W., Prokharau, A., Alsina, M., Ghidini, M., Faustino, C., Gorbunova, V., Zhavrid, E.A., Nishikawa, K., Hosokawa, A., Ganea, D., Yalçın, Ş, Beretta, G.D., Winkler, R.E., Makris, L., Doi, T., Ilson, D.H.

Volltext

Phase III KEYNOTE-585 study of chemotherapy (Chemo) + pembrolizumab (Pembro) vs chemo + placebo as neoadjuvant/adjuvant treatment for patients (Pts) with gastric or gastroesophagea... von Bang, Y.-J., Van Cutsem, E., Fuchs, C.S., Ohtsu, A., Tabernero, J., Ilson, D.H., Hyung, W.J., Strong, V.E., Goetze, T.O., Yoshikawa, T., Tang, L.H., Hwang, P.M.T., Adelberg, D., Shitara, K.

Volltext

Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer von Van Cutsem, E., Hochster, H., Shitara, K., Mayer, R., Ohtsu, A., Falcone, A., Yoshino, T., Doi, T., Ilson, D.H., Arkenau, H.-T., George, B., Benhadji, K.A., Makris, L., Tabernero, J.

Volltext

The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congre... von Van Laethem, J-L, Carneiro, F, Ducreux, M, Messman, H, Lordick, F, Ilson, D H, Allum, W H, Haustermans, K, Lepage, C, Matysiak-Budnik, T, Cats, A, Schmiegel, W, Cervantes, A, Van Cutsem, E, Rougier, Ph, Seufferlein, Th

Volltext

Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study von Tabernero, J., Shitara, K., Zaanan, A., Doi, T., Lorenzen, S., Van Cutsem, E., Fornaro, L., Catenacci, D.V.T., Fougeray, R., Moreno, S.R., Azcue, P., Arkenau, H.-T., Alsina, M., Ilson, D.H.

Volltext

Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy von Molena, D., Sun, H. H., Badr, A. S., Mungo, B., Sarkaria, I. S., Adusumilli, P. S., Bains, M. S., Rusch, V. W, Ilson, D. H., Rizk, N. P.

Volltext

Targeted Therapies for Esophageal Cancer von Tew, William P., Kelsen, David P., Ilson, David H.

Volltext

Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma von Kawakami, Kazuyuki, Brabender, Jan, Lord, Reginald V., Groshen, Susan, Greenwald, Bruce D., Krasna, Mark J., Yin, Jing, Fleisher, A. Steven, Abraham, John M., Beer, David G., Sidransky, David, Huss, Harold T., Demeester, Tom R., Eads, Cindy, Laird, Peter W., Ilson, David H., Kelsen, David P., Harpole, David, Moore, Mary-Beth, Danenberg, Kathleen D., Danenberg, Peter V., Meltzer, Stephen J.

Volltext

Cytogenetic analysis of 124 prospectively ascertained male germ cell tumours von RODRIGUEZ, E, MATHEW, S, REUTER, V, ILSON, D. H, BOSL, G. J, CHAGANTI, R. S. K

Volltext

Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma von Gerber, N., Ilson, D. H., Wu, A. J., Janjigian, Y. Y., Kelsen, D. P., Zheng, J., Zhang, Z., Bains, M. S., Rizk, N., Rusch, V. W., Goodman, K. A.

Volltext

Chemotherapy and Combined-Modality Therapy for Esophageal Cancer von Kelsen, David P., Ilson, David H.

Volltext